World's Best Scientists 2026 revealed!
Emanuela Marcenaro

Emanuela Marcenaro

D-Index & Metrics

Immunology

D-Index
61
Citations
15920
World Ranking
3209
National Ranking
123

Emanuela Marcenaro publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Emanuela Marcenaro sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 136 publications — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Emanuela Marcenaro D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Emanuela Marcenaro sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 61 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Emanuela Marcenaro is a researcher affiliated with the University of Genoa in Italy. Their work primarily spans the fields of Medicine and Immunology and Microbiology, with significant contributions to the subfields of Immunology, Oncology, Surgery, Reproductive Medicine, and Infectious Diseases.

The scientist's research topics include:

  • Immune Cell Function and Interaction
  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • T-cell and B-cell Immunology
  • Ovarian cancer diagnosis and treatment
  • Bladder and Urothelial Cancer Treatments
  • Lymphoma Diagnosis and Treatment

Frequent publication venues for Marcenaro's research are:

  • Frontiers in Immunology
  • Cancers
  • Zenodo (CERN European Organization for Nuclear Research)
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Treatment Reviews

Among notable recent papers authored or co-authored by Marcenaro are:

  • Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells, 2021, Nature
  • Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing, 2022, Nature Communications
  • NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer, 2022, Cancer Cell
  • NKG2A expression identifies a subset of human Vδ2 T cells exerting the highest antitumor effector functions, 2021, Cell Reports
  • New Insights into Endometrial Cancer, 2021, Cancers

Marcenaro has collaborated extensively with a number of frequent co-authors, including Silvia Pesce, Marco Greppi, Simona Candiani, Valentina Obino, and Matteo Bozzo.

Best Publications

  • Identification and Molecular Characterization of Nkp30, a Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells

    Daniela Pende;Silvia Parolini;Anna Pessino;Simona Sivori

  • NKp44, a Novel Triggering Surface Molecule Specifically Expressed by Activated Natural Killer Cells, Is Involved in Non–Major Histocompatibility Complex–restricted Tumor Cell Lysis

    Massimo Vitale;Cristina Bottino;Simona Sivori;Lorenza Sanseverino

  • Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors: Consequences for the NK-mediated killing of dendritic cells

    Roberta Castriconi;Claudia Cantoni;Mariella Della Chiesa;Massimo Vitale

  • Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals.

    Domenico Mavilio;Gabriella Lombardo;Janet Benjamin;Diana Kim

  • NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells

    Simona Sivori;Daniela Pende;Cristina Bottino;Emanuela Marcenaro

  • Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia.

    Régis T. Costello;Simona Sivori;Emanuela Marcenaro;Marina Lafage-Pochitaloff

  • NK cells at the interface between innate and adaptive immunity

    A Moretta;E Marcenaro;S Parolini;G Ferlazzo

  • The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues.

    Silvia Parolini;Amerigo Santoro;Emanuela Marcenaro;Walter Luini

  • Natural killer cells in HIV-1 infection: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates

    Domenico Mavilio;Janet Benjamin;Marybeth Daucher;Gabriella Lombardo

  • Gntb-A, a Novel Sh2d1a-Associated Surface Molecule Contributing to the Inability of Natural Killer Cells to Kill Epstein-Barr Virus–Infected B Cells in X-Linked Lymphoproliferative Disease

    Cristina Bottino;Michela Falco;Silvia Parolini;Emanuela Marcenaro

  • Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization.

    Silvia Pesce;Marco Greppi;Giovanna Tabellini;Fabio Rampinelli

  • 2B4 functions as a co-receptor in human NK cell activation

    Simona Sivori;Silvia Parolini;Michela Falco;Emanuela Marcenaro

  • Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells

    Mario Witkowski;Mario Witkowski;Caroline Tizian;Marta Ferreira-Gomes;Daniela Niemeyer;Daniela Niemeyer

  • Human Natural Killer Cells Prevent Infectious Mononucleosis Features by Targeting Lytic Epstein-Barr Virus Infection

    Obinna Chijioke;Anne Müller;Regina Feederle;Mario Henrique M. Barros

  • Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation

    Lorenzo Moretta;Franco Locatelli;Daniela Pende;Emanuela Marcenaro

  • Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation

    Simona Sivori;Michela Falco;Emanuela Marcenaro;Silvia Parolini

  • Early liaisons between cells of the innate immune system in inflamed peripheral tissues

    Alessandro Moretta;Emanuela Marcenaro;Emanuela Marcenaro;Simona Sivori;Mariella Della Chiesa

  • Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection

    Domenico Mavilio;Gabriella Lombardo;Audrey Kinter;Manuela Fogli

  • Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis

    Sara Trabanelli;Mathieu F. Chevalier;Amaia Martinez-Usatorre;Alejandra Gomez-Cadena

  • IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors

    Simona Sivori;Claudia Cantoni;Claudia Cantoni;Silvia Parolini;Emanuela Marcenaro

  • CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies

    Simona Sivori;Massimo Vitale;Cristina Bottino;Emanuela Marcenaro

Frequent Co-Authors

Alessandro Moretta
Alessandro Moretta University of Genoa
Lorenzo Moretta
Lorenzo Moretta Bambino Gesù Children's Hospital
Simona Sivori
Simona Sivori University of Genoa
Domenico Mavilio
Domenico Mavilio University of Milan
Claudia Cantoni
Claudia Cantoni University of Genoa
Cristina Bottino
Cristina Bottino University of Genoa
Daniela Pende
Daniela Pende University of Genoa
Massimo Vitale
Massimo Vitale University of Genoa
Roberto Biassoni
Roberto Biassoni Istituto Giannina Gaslini
Michela Falco
Michela Falco Istituto Giannina Gaslini

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology opens diverse career pathways, often intersecting with nursing and healthcare specialties. For those interested in advanced clinical roles, understanding the highest paid DNP specialties can guide your specialization choices and potential earnings.

Nurses aiming to expand their scope might consider transitioning, such as moving from a Family Nurse Practitioner (FNP) to an Acute Care NP role. This transition requires additional training but can lead to more specialized and critical care opportunities. Resources like the FNP to acute care NP guide help clarify this pathway.

For those pursuing nursing degrees online, accelerated programs provide a fast track to advanced practice roles. The accelerated FNP program is a popular option for candidates ready to advance quickly without sacrificing quality education.

Beginners without a nursing background can also enter the field through online programs such as the online ABSN programs for non nurses. These programs offer a streamlined path to becoming registered nurses, who can later specialize in immunology-related health care disciplines.

Best Scientists Citing Emanuela Marcenaro

Trending Scientists

Recently Published Articles